Dr. Noah Davidsohn—Gene Therapies for Age-Related Diseases
Longevity by Design
00:00
Is There a Target for RJBO2?
TGF-beta receptor 2 and alpha-quiltho have been shown to work in heart failure, kidney failure, and osteoarthritis. There's a number of different applications for RJBO2 as well. Osteoarthritis is our first target, but could potentially expand into other things. And the next question is related, okay, what are the age-related diseases? So what are the target that you are going to approach first and maybe why?
Transcript
Play full episode
